Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Visual Agnosia01:12

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round end"...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Depth Perception and Spatial Vision01:15

Depth Perception and Spatial Vision

Depth perception is the ability to perceive objects three-dimensionally. It relies on two types of cues: binocular and monocular. Binocular cues depend on the combination of images from both eyes and how the eyes work together. Since the eyes are in slightly different positions, each eye captures a slightly different image. This disparity between images, known as binocular disparity, helps the brain interpret depth. When the brain compares these images, it determines the distance to an object.
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Reports and Case Studies: An Endangered Species.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2025
Same author

A Real-World Single-Center Cohort Study on the Tolerability of Trastuzumab Deruxtecan for HER2+ Metastatic Breast Cancer.

Oncology·2025
Same author

A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer.

NPJ breast cancer·2025
Same author

Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial.

JAMA oncology·2024
Same author

Promoting Growth in Behavioral Neurology: A Path Forward.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2024
Same author

Deepak N. Pandya: A tribute.

The Journal of comparative neurology·2023
Same journal

The role of disadvantaged childhood conditions on cognitive function and disability in late life: findings from a Swedish longitudinal study.

Journal of clinical and experimental neuropsychology·2026
Same journal

Assessment of facial emotion recognition accuracy and reaction time in patients with social anxiety disorder diagnosed with performance-only specifier.

Journal of clinical and experimental neuropsychology·2026
Same journal

Stability and accuracy of specific learning disability diagnoses from childhood to young adulthood.

Journal of clinical and experimental neuropsychology·2026
Same journal

Performance validity test failure rates among neuropsychological outpatients clinically referred for persistent Long COVID cognitive symptoms following mild SARS-CoV-2 disease severity.

Journal of clinical and experimental neuropsychology·2026
Same journal

Correction.

Journal of clinical and experimental neuropsychology·2026
Same journal

A 50-year personal odyssey through the story of learning disabilities: from primary school to adult LD diagnoses.

Journal of clinical and experimental neuropsychology·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Visual-spatial disembedding in Parkinson's disease.

Gregory P Crucian1, Sheyan Armaghani, Avan Armaghani

  • 1University of Canterbury, Christchurch, New Zealand 8140. greg.crucian@canterbury.ac.nz

Journal of Clinical and Experimental Neuropsychology
|June 2, 2009
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) impairs visual-spatial disembedding, a skill involving attention to visual stimuli. This deficit in Parkinson's patients did not improve with medication, suggesting other neurological factors are involved.

More Related Videos

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
11:12

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
07:12

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Jun 22, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
11:12

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
07:12

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

Published on: April 11, 2025

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Neurology

Background:

  • Parkinson's disease (PD) is frequently linked to visual-spatial impairments.
  • The specific impact of PD on visual-spatial disembedding remains unclear.
  • Disembedding involves visual scanning and spatial attention allocation.

Purpose of the Study:

  • To determine if individuals with PD exhibit deficits in visuospatial disembedding.
  • To investigate whether dopaminergic treatment affects this disembedding ability.
  • To explore correlations between disembedding, other cognitive functions, and PD symptoms.

Main Methods:

  • Comparative study involving Parkinson's disease patients and matched controls.
  • Assessment of PD participants both on and off dopaminergic medication.
  • Utilized the Hidden Patterns Test (HPT) and frontal-executive function tests.

Main Results:

  • PD patients demonstrated significant difficulties with visual-spatial disembedding.
  • This deficit was independent of medication status, disease duration, severity, or specific symptoms.
  • Performance was linked to challenges in visual scanning and spatial attention.
  • No improvement in disembedding was observed after dopaminergic treatment.

Conclusions:

  • PD is associated with impaired visual-spatial disembedding, potentially linked to visual scanning and attention.
  • The lack of response to dopaminergic treatment suggests involvement of non-dopaminergic systems or neurodegeneration in specific brain areas.
  • Further research is needed to elucidate the underlying neurobiological mechanisms.